You have 9 free searches left this month | for more free features.

fondaparinux

Showing 1 - 25 of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Venous Thromboembolism Trial (Fondaparinux, Enoxaparin)

Terminated
  • Venous Thromboembolism
  • (no location specified)
Apr 7, 2022

Medical Patient, Thrombocytopenia Trial in Chieti (Fondaparinux)

Terminated
  • Medical Patient
  • Thrombocytopenia
  • Fondaparinux
  • Chieti, Italy
    Marcello Di Nisio
Jul 14, 2021

Heparin-Induced Thrombocytopenia Trial in Louisville (fondaparinux, warfarin)

Terminated
  • Heparin-Induced Thrombocytopenia
  • Louisville, Kentucky
    University of Louisville Hospital
Oct 24, 2019

Heparin-Induced Thrombocytopenia Trial (fondaparinux, argatroban or lepirudin)

Withdrawn
  • Heparin-Induced Thrombocytopenia
  • fondaparinux
  • argatroban or lepirudin
  • (no location specified)
Aug 12, 2019

Pneumonia, Viral, Corona Virus Infection, Respiratory Failure Trial in Milano (Tirofiban Injection, Clopidogrel, Acetylsalicylic

Completed
  • Pneumonia, Viral
  • +3 more
  • Tirofiban Injection
  • +3 more
  • Milano, Lombardia, Italy
    L. Sacco Hospital
Apr 28, 2020

Deep Venous Thrombosis, Pulmonary Embolism Trial in Baltimore (Enoxaparin, Fondaparinux)

Completed
  • Deep Venous Thrombosis
  • Pulmonary Embolism
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Jun 5, 2019

Thromboembolism Trial (Fondaparinux)

Completed
  • Thromboembolism
  • Fondaparinux
  • ,
    GSK Investigational Site
Aug 30, 2018

Thrombosis, Venous Trial (Fondaparinux)

Completed
  • Thrombosis, Venous
  • Fondaparinux
  • ,
    GSK Investigational Site
Aug 30, 2018

Venous Thromboembolism Trial in Asahikawa (15mg DU-176b, 30mg DU-176b, Fondaparinux)

Completed
  • Venous Thromboembolism
  • 15mg DU-176b
  • +2 more
  • Asahikawa, Hokkaido Prefecture, Japan
    Toyooka Chuo Hospital
Feb 8, 2019

Patients With Acute Heparin-induced Thrombocytopenia Type II

Completed
  • Acute HIT II (Heparin-induced Thrombocytopenia Type II)
  • (no location specified)
Jun 6, 2017

Stable Acute Pulmonary Embolism: Once Daily Subcutaneous

Withdrawn
  • Pulmonary Embolism
  • Fondaparinux
  • Cleveland, Ohio
    Cleveland Clinic 9500 Euclid Ave.
Jan 26, 2017

Injectable Anticoagulants for Thromboprophylaxis Post

Completed
  • Thrombosis, Venous
  • (no location specified)
May 15, 2017

Thromboembolism Trial (Fondaparinux, enoxaparin)

Completed
  • Thromboembolism
  • (no location specified)
Sep 13, 2016

Superficial Vein Thrombosis Trial in Germany (Rivaroxaban, Fondaparinux)

Completed
  • Superficial Vein Thrombosis
  • Freiburg, Baden-Württemberg, Germany
  • +22 more
Sep 12, 2016

Morbid Obesity Trial in Indianapolis (fondaparinux)

Withdrawn
  • Morbid Obesity
  • fondaparinux
  • Indianapolis, Indiana
    Clarian Bariatric Center
Feb 22, 2016

Venous Thromboembolism Trial in Detroit (Fondaparinux)

Completed
  • Venous Thromboembolism
  • Fondaparinux
  • Detroit, Michigan
    Detroit Medical Center
Jun 18, 2015

Fondaparinux EU-RMP (Adherence)

Completed
  • Acute Coronary Syndrome
  • fondaparinux
  • (no location specified)
Apr 23, 2015

Thrombosis, Heparin-induced Thrombocytopenia Trial in United States (Fondaparinux)

Completed
  • Thrombosis
  • Heparin-induced Thrombocytopenia
  • Fondaparinux
  • Los Angeles, California
  • +3 more
Apr 14, 2015

Ovarian Carcinoma Trial in New York (Fondaparinux)

Withdrawn
  • Ovarian Carcinoma
  • Fondaparinux
  • New York, New York
    NYU Cancer Institute Clinical Cancer Center
Mar 16, 2015

ARIXTRA® Adherence in SVT Patients.

Completed
  • Thrombosis, Venous
  • Fondaparinux
  • (no location specified)
Mar 26, 2015

Kidney Diseases Trial in Durham (fondaparinux)

Withdrawn
  • Kidney Diseases
  • fondaparinux
  • Durham, North Carolina
    Duke University Medical Center
Jul 25, 2014

Lung Tumors, Esophageal Tumors, Venous Thromboembolism Trial in Shanghai (Fondaparinux, Nadroparin Calcium)

Completed
  • Lung Neoplasms
  • +2 more
  • Fondaparinux
  • Nadroparin Calcium
  • Shanghai, China
    Zhongshan Hospital
Apr 28, 2014

Pulmonary Embolism Trial in Duluth (Fondaparinux)

Withdrawn
  • Pulmonary Embolism
  • Fondaparinux
  • Duluth, Minnesota
    St. Mary's Medical Center
May 28, 2013

Deep Vein Thrombosis, Pulmonary Embolism Trial in Netherlands (Nadroparin, Fondaparinux)

Unknown status
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Nijmegen, Gelderland, Netherlands
  • +4 more
Dec 15, 2012

Fibrillation, Atrial Trial in France, Germany (fondaparinux, unfractionated heparin, Vitamin-K-Antagonist)

Completed
  • Fibrillation, Atrial
  • fondaparinux
  • +2 more
  • Albi, France
  • +33 more
Sep 20, 2012